DUAL-ANTIBAX CREAM
BOOTH NO : G9
Category : Health, Wellness & Wellbeing
Dual-Antibax cream contains Dual-Antibax powder containing two antibacterial agents in a carriers system. The cream can be used to treat some skin conditions by killing bacteria or prevent bacterial growth. The process of producing Dual-Antibax has been granted utility innovation (UI2013700023), and it is now in the market-ready prototype stage. The novelty is based on the claims in the IPR, which state that there are two processes for Dual-Antibax production: (1) silver-kaolinite production, and then (2) surfactant attachment. This product's value proposition is the immediate effect for skin problem treatment with high efficacy and low cost, safe to human and based on a strong scientific approach. To create a larger market size, the cream's concept is similar to that of a cosmetic rather than a typical clinical product. In the near future, the product will enter the market through various market segments, including baby, health and beauty, and pet treatment products.
When germs or bacteria infect the skin, the condition worsens, resulting in an infected skin problem. The cost structure of treatment is like an iceberg, with 20% representing material costs and the remainder (bottom of the ice) representing nursing and hospitalisation costs. As a result, preventing the skin problem from worsening is critical, especially in Malaysia, where the tropical climate encourages bacterial growth. In most cases, skin problems are treated with antibiotic or hormone cream, which can be obtained from clinics and pharmacies. Antibiotics, on the other hand, cause bacterial resistance. As a result, the Dual-Antibax cream can be used replacing these creams. Inside the Dual-Antibax cream, there are two (dual) antibacterial agents: silver ions and a surfactant in a kaolinite carrier system. The kaolinite is used as a carrier system for these two antibacterial agents, reducing their amount while maintaining high effectiveness.
Dual-Antibax cream combines products for human skin's health and beauty, as well as acting as a biocompatible antibacterial agent.
Malaysia's skin care products market was worth $804.5 million in 2019 and is expected to be worth $1,288.7 million by 2027. (Allied Market Research). The market is expanding positively.
Antimicrobial ingredients market worth $7+ billion as global forecasts from 2019 to 2024: Antimicrobial agents are increasingly being used in cosmetic and personal care products (www.prnewswire.com).
Because of COVID19 and MCO, everyone is looking for an effective antimicrobial agent, and the online marketplace is rapidly expanding, allowing the Dual-Antibax cream to be sold through this platform.
Everyone with skin problems, including babies, toddlers, teenagers, and adults with skin problems and allergies, as well as diabetic patients and others, can use this product.
The Dual-Antibax cream may provide an alternative product to meet the high demand for antimicrobial products.
Dual-Antibax cream contains two antibacterial agents in a carrier system at a lower concentration due to an optimized calculation of kaolinite Cation Exchange Capacity.
Because of their synergistic effects, a lower concentration of two antibacterial agents can still be effective.
The Dual-Antibax is a new market segmentation based on hybrid organic-inorganic material technology.
The following proposed project is to use precommercialization funding to achieve TRL7 to TRL9.
The development of Dual-Antibax is based on strong scientific principles, making it difficult to replicate the product's recipe.
The Dual-Antibax cream contains three components: silver ion, surfactant, and kaolinite. Because these elements are common, they are easily obtained.
The production cost is low because there are no complicated machines, chemicals, waste, high temperatures, or solvents involved.
Because of the synergistic effect of the two antibacterial agents, the effect of this product is immediate.
The use of kaolinite as a carrier system can reduce the amount of silver ions and surfactant, and kaolinite is an abundant mineral in Malaysia.
When we compare Dual-Antibax cream to other antibacterial products on the market, the Dual-Antibax cream comes out on top.
Daktarin cream, gentamicin cream, and econazine cream are examples of competitors that are available in pharmacies.
Most competitors in the market use chemical antibiotics as active ingredients, but in the Dual-Antibax cream, we use a low amount of surfactant and silver ions in kaolinite materials.
Antibiotics may cause bacterial resistance, rendering them ineffective and strengthening the bacteria.
Dual-antibax contains two antibacterial agents in a carrier system, which makes it effective antibacterial due to the synergistic effects of the two antibacterial agents.
A few industrial partners have been identified, ranging from manufacturing to packaging, KKM approval, distribution, marketing, and selling.
Based on a patent licensing agreement with UTM, ClayNIQ Enterprise will manufacture the Dual-Antibax powder.
The production of market-ready Dual-Antibax cream will then be carried out by Biopro Consortium Sdn Bhd, which has a GMP (Good Manufacturing Practice) facility.
Youbaby Millions Sdn Bhd and ClayRa Beauty and Health Enterprise will market and distribute the Dual-Antibax cream.
By strategizing this commercialization approach, the ClayNIQ Enterprise will be able to find other suitable companies to market, distribute, and sell the product in various market segments.
NIK AHMAD NIZAM BIN NIK MALEK
FAKULTI SAINS
IBRAHIRUL QAMIL BIN ISMAIL
SCIENCE
JUAN BIN MATMIN
FAKULTI SAINS
KHAIRUNADWA BINTI JEMON
FAKULTI SAINS
MARIANI BINTI ABDUL HAMID
FAKULTI KEJURUTERAAN KIMIA DAN KEJURUTERAAN TENAGA
MUHAMMAD HARIZ ASRAF BIN HASSAN
SCIENCE
NOR SURIANI BINTI SANI
JABATAN TIMBALAN NAIB CANSELOR (PENYELIDIKAN DAN INOVASI)
TS DR. MOHD ALIFF AFIRA SANI
UNIVERSITI KUALA LUMPUR
ZURAIDAH BINTI SULAIMAN
FAKULTI PENGURUSAN